SOPHiA GENETICS (SOPH) Total Non-Current Liabilities (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Total Non-Current Liabilities data on file, last reported at $65.4 million in Q4 2025.

• For the quarter ending Q4 2025, Total Non-Current Liabilities rose 104.14% year-over-year to $65.4 million; the trailing twelve-month figure through Dec 2025 stood at $65.4 million (up 104.14% YoY), and the FY2025 full-year result was $65.4 million, up 104.14% from the prior year.
• Total Non-Current Liabilities fell to $65.4 million in Q4 2025, from $65.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $66.4 million in Q2 2025 to a low of $8.0 million in Q2 2021.
• A 5-year average of $27.8 million and a median of $18.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Peak annual rise in Total Non-Current Liabilities reached 125.7% in 2022, while the deepest fall reached 4.65% in 2022.
• Tracing SOPH's Total Non-Current Liabilities over 5 years: stood at $16.2 million in 2021, then advanced by 4.5% to $16.9 million in 2022, then advanced by 12.99% to $19.1 million in 2023, then jumped by 67.68% to $32.0 million in 2024, then soared by 104.14% to $65.4 million in 2025.
• Business Quant data shows SOPH's Total Non-Current Liabilities at $65.4 million in Q4 2025, $65.8 million in Q3 2025, and $66.4 million in Q2 2025.